Matthew Jackson2 said:Coming from the same person who spent all this time trying to explain that things aren't just binary—that they aren't just zeros and ones, but can exist somewhere in the middle.
At this stage, the level of evidentiary certainty regarding safety is significantly lower than what we see with mandatory vaccines that have been in use for decades, even if it does technically sit above the threshold we’ve collectively decided is acceptable.
This isn't anything new. And calling them experimental is a lie that won't fly here.☕
Well, that largely comes down to semantics. However, there are certain facts that don't depend on how you choose to label them:
- the vaccine does not meet the requirements for a standard MA
- data—not just the long-term stuff collected for all drugs and vaccines, but the very data required for a regular MA, which is still being gathered
- using that exact same dataset, the vaccine received emergency approval in the USA, which is effectively authorization to use an experimental vaccine.
Whether you want to call it experimental, semi-experimental, or non-experimental is entirely your prerogative, but those underlying facts remain unchanged regardless of the label you slap on them.
No. I was quoting a specific post that was making a general point about vaccines.
Actually, no, you were quoting a specific post that compares potential unknown long-term side effects of a vaccine against the potential unknown long-term consequences of the virus itself.
With a vaccine, that represents an acceptable risk we accept because of the necessity of the shot (which is essentially the definition of CMA), but that risk isn't equally justifiable across every single age group. Comparing it to the virus is nothing more than pure whataboutism, the likes of which I haven't seen in medical discourse before.
Nothing I said contradicts that at all. ☕
The level of evidence regarding safety at this stage is way lower than what we see with mandatory vaccines that have been used for years, even if it stays above the threshold we decided was acceptable.
And those "long-standing" mandatory vaccines were also
new once upon a time.
That mostly comes down to definitions. Here are the facts that don't care about your definitions:
- the vaccine doesn't meet the requirements for standard MA
- data—not just the long-term stuff collected for all drugs and vaccines, but the kind of data required for regular MA—is still being collected
- using that same dataset, the vaccine in the USA received emergency approval, which is basically an authorization to use an experimental vaccine.
There's no such thing as CMA in the USA, so it's not clear how a vaccine that cleared all major phases and met its primary endpoints for safety and efficacy gets fast-tracked without it being an EUA.
btw go study the difference between full FDA approval and an EUA.
https://vaccine.unchealthcare.org/sc...-fda-approval/An EUA does not affect vaccine safety, because it does not impact development, such as research, clinical studies and the studying of side effects and adverse reactions. Instead, it speeds up manufacturing and administrative processes.
If a vaccine lacks safety evidence, it’s experimental—period. I don't care how much mental gymnastics people try to pull to spin it otherwise.
Whether you call it experimental, semi-experimental, or non-experimental doesn't matter—those labels don't change the reality.
I'm not calling it experimental or semi-experimental. I'm calling it a vaccine that got CMA/EUA based on efficacy and safety data, and that's exactly how I'm going to treat it. Calling it "experimental" or trying to soften it with "semi-experimental" is malicious because it's nowhere near the truth.
Nah, you're just quoting a post that compares potential unknown long-term vaccine side effects against the possible unknown long-term consequences of the virus itself.
Yeah. Basically.